The study evaluated the effectiveness of mobile health (mHealth) management using an implantable glucose sensor and a mobile app for patients with type 2 diabetes in China.
A randomized controlled trial involved 68 patients split into an intervention group (mHealth management) and a control group (usual management) over four weeks, with no significant differences in key health metrics before the intervention.
Results showed that the intervention group experienced significant improvements in BMI, fasting and postprandial blood glucose levels, and quality of life compared to the control group, suggesting mHealth management is a promising approach for diabetes care.